d-Cycloserine enhances implicit memory in Alzheimer patients

Neurology

Volumn 46, Issue 2, 1996, Pages 420-424

  Schwartz, B L ^a   Hashtroudi, S ^b   Herting, R L ^c   Schwartz, P ^c   Deutsch, S I ^a,d  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c PFIZER INC   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSERINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLACEBO;

ADULT; AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; CHOLINERGIC TRANSMISSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TASK PERFORMANCE;

EID: 0029881660     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.2.420     Document Type: Article

References (31)

1. Collingridge GL, Bliss TVP. NMDA receptors - their role in long-term potentiation. Trends Neurosci 1987;10:288-293.
2. Monahan JB, Handelmann GE, Hood WF, Cordi AA. d-Cycloserine, a positive modulator of the N-methyl-D-aspartate receptor, enhances performance of learning tasks in rats. Pharmacol Biochem Behav 1989;34:649-653.
3. Morris RGM, Anderson E, Lynch GS, Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 1986;319:774-776.
4. Kleckner NW, Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in xenopus oocytes. Science 1988;241:835-837.
5. Hood WF, Compton RP, Monahan JB. d-Cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics. Neurosci Lett 1989;98:91-95.
6. Lanthorn TH. d-Cycloserine: agonist turned antagonist. Amino Acids 1994;6:247-260.
7. Baxter MG, Lanthorn TH, Frick KM, Golski S, Wan R, Olton DS. d-Cycloserine, a novel cognitive enhancer, improves spatial memory in aged rats. Neurobiol Aging 1994;15:207-213.
8. Jones RW, Wesnes KA, Kirby J. Effects of NMDA modulation in scopolamine dementia. Ann NY Acad Sci 1991;640:241-244.
9. Drachman DA, Leavitt J. Human memory and the cholinergic system. Arch Neurol 1974;30:113-121.
10. Wesnes K, Simpson P, Kidd A. An investigation of the range of cognitive impairments induced by scopolamine 0.6 mg s.c. Hum Psychopharmacol 1988;3:27-41.
11. Schacter DL. Implicit memory: history and current status. J Exp Psychol [Learn Mem Cogn] 1987;13:501-518.
12. Bondi MW, Kaszniak AW. Implicit and explicit memory in Alzheimer's disease and Parkinson's disease. J Clin Exp Neuropsychol 1991;13:339-358.
13. Heindel WC, Salmon DP, Butters N. Pictorial priming and cued recall in Alzheimer's and Huntington's disease. Brain Cogn 1990;13:282-295.
14. Salmon DP, Shimamura AP, Butters N, Smith S. Lexical and semantic priming deficits in patients with Alzheimer's disease. J Clin Exp Neuropsychol 1988;10:477-494.
15. Shimamura AP, Salmon DP, Squire LR, Butters N. Memory dysfunction and word priming in dementia and amnesia. Behav Neurosci 1987;101:347-351.
16. Searle clinical research report. A two year, multicenter, randomized, double-blind controlled parallel group study of cycloserine in the treatment of Alzheimer's disease with six months placebo control. Report No. NC6-93-06-009, September 29, 1993. Skokie, IL: GD Searle, 1993.
17. Schwartz BL, Hashtroudi S. Priming is independent of skill learning. J Exp Psychol [Learn Mem Cogn] 1991;17:1177-1187.
18. Ostergaard AL. Dissociations between word priming effects in normal subjects and patients with memory disorders: multiple memory systems or retrieval? Q J Exp Psychol 1994;47A:331-364.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
20. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
21. Reisberg B, Ferris SH, De Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-1139.
22. Small GW. Revised ischemic score for diagnosing multi-infarct dementia. J Clin Psychiatry 1985;46:514-517.
23. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296.
24. Mattis S. Dementia rating scale. Odessa, FL: Psychological Assessment Resources, 1988.
25. Balota DA, Duchek JM. Semantic priming effects, lexical repetition effects, and contextual disambiguation effects in healthy aged individuals and individuals with senile dementia of the Alzheimer type. Brain Lang 1991;40:181-201.
26. Ober BA, Shenaut GK. Lexical decision and priming in Alzheimer's disease. Neuropsychologia 1988;26:273-286.
27. Schwartz BL, Hashtroudi S, Herting RL, Handerson H, Deutsch SI. Glycine prodrug facilitates memory retrieval in humans. Neurology 1991;41:1341-1343.
28. Thompson LT, Moskal JR, Disterhoft JF. Hippocampus-dependent learning facilitated by a monoclonal antibody or d-cycloserine. Nature 1992;359:638-641.
29. Gabrieli JDE, Keane MM, Stanger BZ, Kjelgaard MM, Corkin S, Growdon JH. Dissociations among structural-perceptual, lexical-semantic, and event-fact memory systems in Alzheimer, amnesic, and normal subjects. Cortex 1994;30:75-103.
30. Squire LR, Ojemann JG, Miezin FM, Petersen SE, Videen TO, Raichle ME. Activation of the hippocampus in normal humans: a functional anatomical study of memory. Proc Natl Acad Sci USA 1992;89:1837-1841.
31. Schwartz BL, Hashtroudi S, Herting RL, Fakouhi TD, Deutsch SI. The NMDA receptor complex: enhancement of memory in aging and dementia. In: Herrmann D, McEvoy C, Hertzog C, Hertel P, Johnson M, eds. Basic and applied memory: research on practical aspects of memory. Hillsdale, NJ: Erlbaum (in press).